Identification of a Selective PDE4B Inhibitor From Bryophyllum pinnatum by Target Fishing Study and In Vitro Evaluation of Quercetin 3- O-α-L -Arabinopyranosyl-(1→2)- O-α-L- Rhamnopyranoside

Natural products are considered an important source of bioactive compounds especially in biodiversity-rich countries like Brazil. The identification of potential targets is crucial to the development of drugs from natural sources. In this context, methodologies, such as inverse virtual screening (ta...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 10; p. 1582
Main Authors Lourenço, Estela M G, Fernandes, Júlia M, Carvalho, Vinícius de F, Grougnet, Raphael, Martins, Marco A, Jordão, Alessandro K, Zucolotto, Silvana M, Barbosa, Euzébio G
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 22.01.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Natural products are considered an important source of bioactive compounds especially in biodiversity-rich countries like Brazil. The identification of potential targets is crucial to the development of drugs from natural sources. In this context, methodologies, such as inverse virtual screening (target fishing), are interesting tools as they are a rational and direct method that reduces costs and experimental time. Among the species of Brazilian biomes, (Lam.) Oken, native to Madagascar, is widely used by the population to treat inflammation conditions. It has a remarkable presence of flavonoids, including quercetin 3- -arabinopyranosyl-(1→2)- rhamnopyranoside ( ), considered one of its major compounds. However, until now there were no studies addressing its putative mechanism of action and explaining its pharmacological action. The enzyme PDE4B, known as an antiinflammatory protein, was indicated as a promising target by target fishing methods. This activity was confirmed by enzymatic inhibition, and an expressive selectivity of PDE4B over PDE4A was demonstrated. The interactions were investigated through molecular dynamics simulations. The results were pioneering, representing an advance in the investigation of the antiinflammatory action of and confirm the potential of the flavonoid as a chemical extract marker. Also, the flavonoid was shown to be a promising lead for the design of other selective PDE4B blockers to treat inflammatory diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Pedro Mena, University of Parma, Italy
Reviewed by: Gerard Pujadas, Rovira i Virgili University, Spain; Ana Paula Simões-Wüst, University Hospital Zürich, Switzerland
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2019.01582